HIV and complement: hijacking an immune defense

2006 Report on the global AIDS epidemic. http://www.unaids.org/en/HIV_data/2006 Global Report/default.asp. UNAIDS, Switzerland. Thurman, 2006, The central role of the alternative complement pathway in human disease, J. Immunol., 176, 1305, 10.4049/jimmunol.176.3.1305 Volanakis, 2002, The role of complement in innate and adaptive immunity, Curr. Top. Microbiol. Immunol., 266, 41 Mastellos, 2005, Complement: an inflammatory pathway fulfilling multiple roles at the interface of innate immunity and development, Curr. Drug Targets Inflamm. Allergy, 4, 125, 10.2174/1568010053622993 Moffitt, 1994, Complement resistance in microbes, Springer Semin. Immunopathol., 15, 327, 10.1007/BF01837364 Rao, 1984, Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome, N. Engl. J. Med., 310, 669, 10.1056/NEJM198403153101101 Tausk, 1986, Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome, J. Clin. Invest., 78, 977, 10.1172/JCI112688 Boyer, 1991, Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4– and antibody-independent fashion, J. Exp. Med., 173, 1151, 10.1084/jem.173.5.1151 Ebenbichler, 1991, Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41, J. Exp. Med., 174, 1417, 10.1084/jem.174.6.1417 Spear, 1991, Direct binding of complement component C1q to human immunodeficiency virus (HIV) and human T lymphotrophic virus-I (HTLV-I) coinfected cells, AIDS Res. Hum. Retroviruses, 7, 579, 10.1089/aid.1991.7.579 Marschang, 1997, Complement activation by HIV-1-infected cells: the role of transmembrane glycoprotein gp41, J. Acquir. Immune Defic. Syndr. Hum. Retrovirol., 14, 102, 10.1097/00042560-199702010-00002 Thielens, 2002, Interaction of C1q and mannan-binding lectin with viruses, Immunobiology, 205, 563, 10.1078/0171-2985-00155 Bajtay, 1998, HIV-1 induces human monocyte-derived macrophages to produce C3 and to fix C3 on their surface, J. Leukoc. Biol., 63, 463, 10.1002/jlb.63.4.463 Bajtay, 2004, Cutting edge: productive HIV-1 infection of dendritic cells via complement receptor type 3 (CR3, CD11b/CD18), J. Immunol., 173, 4775, 10.4049/jimmunol.173.8.4775 Banki, 2005, Complement dependent trapping of infectious HIV in human lymphoid tissues, AIDS, 19, 481, 10.1097/01.aids.0000162336.20439.8d Bouhlal, 2002, Opsonization of HIV-1 by semen complement enhances infection of human epithelial cells, J. Immunol., 169, 3301, 10.4049/jimmunol.169.6.3301 Bouhlal, 2001, Soluble CD16 inhibits CR3 (CD11b/CD18)-mediated infection of monocytes/macrophages by opsonized primary R5 HIV-1, J. Immunol., 166, 3377, 10.4049/jimmunol.166.5.3377 Delibrias, 1994, CR1(CD35) and CR2(CD21) complement C3 receptors are expressed on normal human thymocytes and mediate infection of thymocytes with opsonized human immunodeficiency virus, Eur. J. Immunol., 24, 2784, 10.1002/eji.1830241131 Dopper, 2003, Mechanism(s) promoting HIV-1 infection of primary unstimulated T lymphocytes in autologous B cell/T cell co-cultures, Eur. J. Immunol., 33, 2098, 10.1002/eji.200323932 Jakubik, 2000, Immune complexes containing human immunodeficiency virus type 1 primary isolates bind to lymphoid tissue B lymphocytes and are infectious for T lymphocytes, J. Virol., 74, 552, 10.1128/JVI.74.1.552-555.2000 Kacani, 2000, Detachment of human immunodeficiency virus type 1 from germinal centers by blocking complement receptor type 2, J. Virol., 74, 7997, 10.1128/JVI.74.17.7997-8002.2000 Malaspina, 2002, Human immunodeficiency virus type 1 bound to B cells: relationship to virus replicating in CD4+ T cells and circulating in plasma, J. Virol., 76, 8855, 10.1128/JVI.76.17.8855-8863.2002 Saifuddin, 1997, Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction, J. Gen. Virol., 78, 1907, 10.1099/0022-1317-78-8-1907 Stoiber, 1995, Human complement proteins C3b, C4b, factor H and properdin react with specific sites in gp120 and gp41, the envelope proteins of HIV-1, Immunobiology, 193, 98, 10.1016/S0171-2985(11)80158-0 Stoiber, 1996, Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55), J. Exp. Med., 183, 307, 10.1084/jem.183.1.307 Hocini, 1999, Infectious human immunodeficiency virus can rapidly penetrate a tight human epithelial barrier by transcytosis in a process impaired by mucosal immunoglobulins, J. Infect. Dis., 179, S448, 10.1086/314802 Hussain, 1995, Investigation of the complement receptor 3 (CD11b/CD18) in human rectal epithelium, Clin. Exp. Immunol., 102, 384, 10.1111/j.1365-2249.1995.tb03794.x De Panfilis, 1990, Human normal-resting epidermal Langerhans cells do express the type 3 complement receptor, Br. J. Dermatol., 122, 127, 10.1111/j.1365-2133.1990.tb08258.x Delibrias, 2000, The enhancing role of complement in human immunodeficiency virus infection: soluble recombinant CR1 (CD35) inhibits complement-mediated enhancement of infection of a CD4-positive T-cell line with human immunodeficiency virus-1, Scand. J. Immunol., 51, 526, 10.1046/j.1365-3083.2000.00715.x Legendre, 1996, Mechanisms of opsonized HIV entry in normal B lymphocytes, FEBS Lett., 381, 227, 10.1016/0014-5793(96)00040-3 Thieblemont, 1993, CR1 (CD35) and CR3 (CD11b/CD18) mediate infection of human monocytes and monocytic cell lines with complement-opsonized HIV independently of CD4, Clin. Exp. Immunol., 92, 106, 10.1111/j.1365-2249.1993.tb05955.x Kacani, 2001, C5a and C5a(desArg) enhance the susceptibility of monocyte-derived macrophage to HIV infection, J. Immunol., 166, 3410, 10.4049/jimmunol.166.5.3410 Thieblemont, 1995, Triggering of complement receptors CR1 (CD35) and CR3 (CD11b/CD18) induces nuclear translocation of NF-kappaB (p50/p65) in human monocytes and enhances viral replication in HIV-infected monocytic cells, J. Immunol., 155, 4861, 10.4049/jimmunol.155.10.4861 Mouhoub, 1996, Ligation of CR1 (C3b receptor, CD35) on CD4+ T lymphocytes enhances viral replication in HIV-infected cells, Clin. Exp. Immunol., 106, 297, 10.1046/j.1365-2249.1996.d01-844.x Nielsen, 1997, Complement-mediated enhancement of HIV-1 infection in peripheral blood mononuclear cells, Scand. J. Infect. Dis., 29, 447, 10.3109/00365549709011852 Gasque, 1998, The receptor for complement anaphylatoxin C3a is expressed by myeloid cells and nonmyeloid cells in inflamed human central nervous system: analysis in multiple sclerosis and bacterial meningitis, J. Immunol., 60, 3543, 10.4049/jimmunol.160.7.3543 Ischenko, 1998, Expression of a functional anaphylatoxin C3a receptor by astrocytes, J. Neurochem., 71, 2487, 10.1046/j.1471-4159.1998.71062487.x Nataf, 1999, Complement anaphylatoxin receptor expression on neurons: new tricks for old receptors?, Trends Neurosci., 22, 397, 10.1016/S0166-2236(98)01390-3 Sayah, 1999, Expression of cytokines by human astrocytomas following stimulation by C3a and C5a anaphylatoxins: specific increase in interleukin-6 mRNA expression, J. Neurochem., 72, 2426, 10.1046/j.1471-4159.1999.0722426.x Morgan, 1997, The role of complement in disorders of the nervous system, Immunopharmacology, 38, 43, 10.1016/S0162-3109(97)00059-3 Depboylu, 2005, Increase of C1q biosynthesis in brain microglia and macrophages during lentivirus infection in the rhesus macaque is sensitive to antiretroviral treatment with 6-chloro-2′,3′-dideoxyguanosine, Neurobiol. Dis., 20, 12, 10.1016/j.nbd.2005.01.030 Speth, 2004, Complement synthesis and activation in the brain of SIV-infected monkeys, J. Neuroimmunol., 151, 45, 10.1016/j.jneuroim.2004.02.013 Kaul, 2005, HIV-1 infection and AIDS: consequences for the central nervous system, Cell Death Differ., S1, 878, 10.1038/sj.cdd.4401623 Di Rocco, 1998, AIDS-associated vacuolar myelopathy, AIDS Patient Care STDS, 12, 457, 10.1089/apc.1998.12.457 Duce, 2006, Activation of early components of complement targets myelin and oligodendrocytes in the aged rhesus monkey brain, Neurobiol. Aging, 27, 633, 10.1016/j.neurobiolaging.2005.03.027 Vanguri, 1982, Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies, Proc. Natl. Acad. Sci. USA, 79, 3290, 10.1073/pnas.79.10.3290 Twining, 2005, Activation of the spinal cord complement cascade might contribute to mechanical allodynia induced by three animal models of spinal sensitization, J. Pain, 6, 174, 10.1016/j.jpain.2004.11.011 Shah, 2006, Update on HIV-associated nephropathy, Curr. Opin. Nephrol. Hypertens., 15, 450, 10.1097/01.mnh.0000232887.58271.67 Quigg, 2004, Complement and autoimmune glomerular diseases, Curr. Dir. Autoimmun., 7, 165, 10.1159/000075692 Monsinjon, 2003, Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells, FASEB J., 17, 1003, 10.1096/fj.02-0737com Castellano, 2005, CD40 ligand increases complement C3 secretion by proximal tubular epithelial cells, J. Am. Soc. Nephrol., 16, 2003, 10.1681/ASN.2002120972 Bruder, 2004, HIV-1 induces complement factor C3 synthesis in astrocytes and neurons by modulation of promoter activity, Mol. Immunol., 40, 949, 10.1016/j.molimm.2003.10.016 Jongen, 2000, Cerebrospinal fluid C3 and C4 indexes in immunological disorders of the central nervous system, Acta Neurol. Scand., 101, 116, 10.1034/j.1600-0404.2000.101002116.x Speth, 2002, Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons, J. Virol., 76, 3179, 10.1128/JVI.76.7.3179-3188.2002 Nakahara, 1996, Effect of macrophage colony-stimulating factor on complement receptors and complement regulatory proteins on human peripheral white blood cells, Arerugi, 45, 1256 Stoiber, 1997, Inhibition of HIV-1 infection in vitro by monoclonal antibodies to the complement receptor type 3 (CR3): an accessory role for CR3 during virus entry?, Mol. Immunol., 34, 855, 10.1016/S0161-5890(97)00108-9 Scott, 1993, In vivo decrease in the expression of complement receptor 2 on B-cells in HIV infection, AIDS, 7, 37, 10.1097/00002030-199301000-00006 Kohleisen, 1999, Stable expression of HIV-1 Nef induces changes in growth properties and activation state of human astrocytes, AIDS, 13, 2331, 10.1097/00002030-199912030-00004 Chong, 2000, Expression of complement inhibitor protein CD59 in human neuronal and glial cell lines treated with HIV-1 gp41 peptides, J. Neurovirol., 6, 51, 10.3109/13550280009006382 Weerth, 2003, Complement C5 in experimental autoimmune encephalomyelitis (EAE) facilitates remyelination and prevents gliosis, Am. J. Pathol., 163, 1069, 10.1016/S0002-9440(10)63466-9 Potash, 2005, A mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuroinvasiveness, Proc. Natl. Acad. Sci. USA, 102, 3760, 10.1073/pnas.0500649102 Zhong, 2005, Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy, Kidney Int., 68, 1048, 10.1111/j.1523-1755.2005.00497.x Gattone, 1998, SIV-associated nephropathy in rhesus macaques infected with lymphocyte-tropic SIVmac239, AIDS Res. Hum. Retroviruses, 14, 1163, 10.1089/aid.1998.14.1163 Hartmann, 1997, C3a and C5a stimulate chemotaxis of human mast cells, Blood, 89, 2863, 10.1182/blood.V89.8.2863 Riedemann, 2002, Expression and function of the C5a receptor in rat alveolar epithelial cells, J. Immunol., 168, 1919, 10.4049/jimmunol.168.4.1919 Yao, 1990, Chemotaxis by a CNS macrophage, the microglia, J. Neurosci. Res., 27, 36, 10.1002/jnr.490270106 Venkatesha, 2005, Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and PI3 kinase, Mol. Immunol., 42, 581, 10.1016/j.molimm.2004.09.009 Takabayashi, 2004, Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells, Surgery, 135, 544, 10.1016/j.surg.2003.09.010 Spear, 1999, Alteration of complement protein levels after antiretroviral therapy in HIV-infected persons, AIDS Res. Hum. Retroviruses, 15, 1713 Apostolski, 1994, Complement dependent cytotoxicity of sensory ganglion neurons mediated by the gp120 glycoprotein of HIV-1, Immunol. Invest., 23, 47, 10.3109/08820139409063432 Izmailova, 2003, HIV-1 Tat reprograms immature dendritic cells to express chemoattractants for activated T cells and macrophages, Nat. Med., 9, 191, 10.1038/nm822